InvestSMART

EMvision Medical Devices Limited (ASX: EMV) - Announcements

Current share price for EMV : $1.880 0.1 (5.62%)+

ASX company news and announcements for EMvision Medical Devices Limited (EMV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EMvision Medical Devices Limited (EMV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EMvision Medical Devices Limited (EMV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EMvision Medical Devices Limited (EMV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$175 EMVision Achieves First Responder Milestone 27 Jun 2022 8:19AM $1.485 $1.880 risen by 26.60%
$175 EMVision Awarded $5m Non-Dilutive Funding via MMI Grant 18 May 2022 9:33AM $1.730 $1.880 risen by 8.67%
$175 Trading Halt 16 May 2022 12:02PM $1.730 $1.880 risen by 8.67%
$175 Pause in Trading 16 May 2022 11:42AM $1.730 $1.880 risen by 8.67%
$175 Cleansing Notice 13 May 2022 5:05PM $1.785 $1.880 risen by 5.32%
$175 Application for quotation of securities - EMV 13 May 2022 5:04PM $1.785 $1.880 risen by 5.32%
$175 EMVision Secures Strategic Agreement With Keysight 4 May 2022 10:07AM $1.940 $1.880 fallen by 3.09%
$175 Trading Halt 2 May 2022 9:41AM $1.940 $1.880 fallen by 3.09%
$175 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2022 9:48AM $1.995 $1.880 fallen by 5.76%
$175 New Appointments to Clinical Advisory Board 9 Mar 2022 8:24AM $1.870 $1.880 risen by 0.53%
$175 S&P DJI Announces March 2022 Quarterly Rebalance 4 Mar 2022 5:02PM $1.980 $1.880 fallen by 5.05%
$175 CEO Half-Year Update 24 Feb 2022 8:04AM $2.000 $1.880 fallen by 6%
$175 Half Yearly Report and Accounts 24 Feb 2022 8:03AM $2.000 $1.880 fallen by 6%
$175 International Stroke Conference New Orleans Presentation 14 Feb 2022 8:18AM $2.160 $1.880 fallen by 12.96%
$175 Change of Director's Interest Notice 7 Feb 2022 9:28AM $2.030 $1.880 fallen by 7.39%
$175 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jan 2022 8:12AM $2.100 $1.880 fallen by 10.48%
$175 Change of Director's Interest Notice 11 Jan 2022 8:24AM $2.560 $1.880 fallen by 26.56%
$175 Notification of cessation of securities - EMV 24 Dec 2021 3:18PM $2.600 $1.880 fallen by 27.69%
$175 Change of Director's Interest Notices x5 23 Dec 2021 8:20AM $2.540 $1.880 fallen by 25.98%
$175 Cleansing Notice 23 Dec 2021 8:20AM $2.540 $1.880 fallen by 25.98%
$175 Application for quotation of securities - EMV 23 Dec 2021 8:19AM $2.540 $1.880 fallen by 25.98%
$175 EMV Technology to be Presented at Prestigious Conference 9 Dec 2021 9:20AM $2.580 $1.880 fallen by 27.13%
$175 EMVision Receives $3.4m Non-Dilutive Funding this Quarter 8 Dec 2021 9:10AM $2.580 $1.880 fallen by 27.13%
$175 Notification regarding unquoted securities - EMV 2 Dec 2021 12:52PM $2.650 $1.880 fallen by 29.06%
$175 Application for quotation of securities - EMV 2 Dec 2021 12:47PM $2.660 $1.880 fallen by 29.32%

201 - 225 of 377 results

Page 9 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.